Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph plus Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients (Abstract in rivista)

Type
Label
  • Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph plus Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients (Abstract in rivista) (literal)
Anno
  • 2010-01-01T00:00:00+01:00 (literal)
Alternative label
  • Esposito, N; Quintarelli, C; Colavita, I; Izzo, B; Peluso, AL; Ruoppolo, M; Del Vecchio, L; Russo, D; Branford, S; Iacobucci, I; Thornquist, M; Barnett, M; Melo, J; Saglio, G; Radich, J; Peter, L; Martinelli, G; Kalebic, T; Hughes, T; Pane, F (2010)
    Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph plus Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients
    in , 2010
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Esposito, N; Quintarelli, C; Colavita, I; Izzo, B; Peluso, AL; Ruoppolo, M; Del Vecchio, L; Russo, D; Branford, S; Iacobucci, I; Thornquist, M; Barnett, M; Melo, J; Saglio, G; Radich, J; Peter, L; Martinelli, G; Kalebic, T; Hughes, T; Pane, F (literal)
Titolo
  • Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph plus Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients (literal)
Prodotto di
Autore CNR

Incoming links:


Autore CNR di
Prodotto
data.CNR.it